The Multiple Sclerosis Society of Canada committed $1 million Thursday to funding a yet-unplanned clinical trial for the controversial liberation treatment.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.